PeptideDB

Anticancer agent 247

CAS: F: C16H18Cl2N4O4S W: 433.31

Anticancer agent 247 (Compound 22o) inhibits cell metastasis, induces cell apoptosis (increases the expression of Bax, p
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Anticancer agent 247 (Compound 22o) inhibits cell metastasis, induces cell apoptosis (increases the expression of Bax, p53, cleaved-caspase 3, and cleaved-PARP). Anticancer agent 247 decreases mitochondrial membrane potential. Anticancer agent 247 activates autophagy through the PI3K-Akt-mTOR signaling pathway, damages intracellular mitochondria and lysosomes, and cause ER stress. Anticancer agent 247 inhibits RPS6 phosphorylation. Anticancer agent 247 is an anticancer agent with low systemic toxicity[1].
Invitro Anticancer agent 247 inhibits cancer cell growth, with IC50s of 3.82 μM (HCT-116), 2.80 μM (HeLa), 5.54 μM (MCF-7), 45.96 (A549), 32.71 μM (HepG2), 13.02 μM (PANC-1) respectively[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Anticancer agent 247 相关抗体:
Formula C16H18Cl2N4O4S
Molar Mass 433.31
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Hao EJ, et al. Discovery, Synthesis, and Activity Evaluation of Novel Five-Membered Sulfur-Containing Heterocyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo. J Med Chem. 2024 Jul 17.